Substrate detection assay

Details for Australian Patent Application No. 2004206887 (hide)

Owner Elixir Pharmaceuticals, Inc.

Inventors Hixon, Jeffrey; McDonagh, Tom; Napper, Andrew

Agent Cullen & Co

Pub. Number AU-A-2004206887

PCT Pub. Number WO2004/064739

Priority 60/440,723 16.01.03 US

Filing date 16 January 2004

Wipo publication date 5 August 2004

International Classifications

C12Q 001/34 Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/064739 Priority application(s): WO2004/064739

26 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206889-A puncturable catheter

2004206886-Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases